Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a pre-surgical study involving subjects with muscle invasive bladder urothelial
cancer, who are candidates for cisplatin ineligible neoadjuvant therapy. It is a one-arm
phase II study in single center.